NCT05240560View on ClinicalTrials.gov

Proof of Concept Study Evaluating BP1.3656 in Patients With Fatigue Following Ischemic Stroke

PHASE2TerminatedINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

January 20, 2023

Primary Completion Date

February 8, 2024

Study Completion Date

February 8, 2024

Conditions

Fatigue

Interventions

DRUG

BP1.3656

Histamine H3 receptor antagonist/inverse agonist

Trial Locations (2)

3010

Inselspital Berne, Bern

33076

Hôpital Pellegrin - CHU BORDEAUX, Bordeaux

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bioprojet

OTHER